[1] Rimal B, Greenberg AK, Rom WN. Basic pathogenetic mechanisms in silicosis:current understanding. Curr Opin Pulm Med, 2005; 11, 169-73. doi:  10.1097/01.mcp.0000152998.11335.24
[2] Chong S, Lee KS, Chung MJ, et al. Pneumoconiosis:comparison of imaging and pathologic findings. Radiographics, 2006; 26, 59-77. doi:  10.1148/rg.261055070
[3] Clark RA. Regulation of fibroplasia in cutaneous wound repair. Am J Med Sci, 1993; 306, 42-8. doi:  10.1097/00000441-199307000-00011
[4] Strieter RM, Keeley EC, Hughes MA, et al. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol, 2009; 86, 1111-8. doi:  10.1189/jlb.0309132
[5] Pilling D, Fan T, Huang D, et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PloS One, 2009; 4, e7475. doi:  10.1371/journal.pone.0007475
[6] Chesney J, Metz C, Stavitsky AB, et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol, 1998; 160, 419-25. doi:  10.1164/rccm.201001-0028OC
[7] Medina A, Ghahary A. Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naive CD4(+) T cells. Mol Cell Biochem, 2011; 346, 89-94. doi:  10.1007/s11010-010-0595-2
[8] Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes:collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol, 2004; 36, 598-606. doi:  10.1016/j.biocel.2003.10.005
[9] Chesney J, Bacher M, Bender A, et al. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA, 1997; 94, 6307-12. doi:  10.1073/pnas.94.12.6307
[10] Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol, 2007; 178, 2000-7. doi:  10.4049/jimmunol.178.4.2000
[11] Pilling D, Gomer RH. Differentiation of circulating monocytes into fibroblast-like cells. Methods Mol Biol, 2012; 904, 191-206. https://www.ncbi.nlm.nih.gov/pubmed/22890933#
[12] Yao W, Liu S, Li J, et al. Silica promotes the transdifferentiation of rat circulating fibrocytes in vitro. Mol Med Rep, 2015; 12, 5828-36. doi:  10.3892/mmr.2015.4212
[13] Abbas I, Verdin A, Escande F, et al. In vitro short-term exposure to air pollution PM2.5-0.3 induced cell cycle alterations and genetic instability in a human lung cell coculture model. Environ Res, 2016; 147, 146-58. doi:  10.1016/j.envres.2016.01.041
[14] Peng X, Moore MW, Peng H, et al. CD4+CD25+FoxP3+ Regulatory Tregs inhibit fibrocyte recruitment and fibrosis via suppression of FGF-9 production in the TGF-β1 exposed murine lung. Front Pharmacol, 2013; 5, 80. http://pubmedcentralcanada.ca/pmcc/articles/PMC4032896/
[15] Liu Y, Yu M, Wu L, et al. The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload. Am J Physiol Heart Circ Physiol, 2010; 298, H2082-92. doi:  10.1152/ajpheart.00747.2009
[16] Weldy CS, Liu Y, Chang YC, et al. In utero and early life exposure to diesel exhaust air pollution increases adult susceptibility to heart failure in mice. Part Fibre Toxicol, 2013; 10, 59. doi:  10.1186/1743-8977-10-59
[17] Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes:differentiation pathway and migration to wound sites. J Immunol, 2001; 166, 7556-62. doi:  10.4049/jimmunol.166.12.7556
[18] Bagnato G, Harari S. Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev, 2015; 24, 102-14. doi:  10.1183/09059180.00003214
[19] Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis:clinical relevance of pathologic classification. Am J Respir Crit Care Med, 1998; 157, 1301-15. doi:  10.1164/ajrccm.157.4.9707039
[20] Peng H, Herzog EL. Fibrocytes:emerging effector cells in chronic inflammation. Curr Opin Pharmacol, 2012; 12, 491-6. doi:  10.1016/j.coph.2012.03.002
[21] Epperly MW, Guo H, Gretton JE, et al. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol, 2003; 29, 213-24. doi:  10.1165/rcmb.2002-0069OC
[22] Wada T, Sakai N, Sakai Y, et al. Involvement of bone-marrow-derived cells in kidney fibrosis. Clin Exp Nephrol, 2011; 15, 8-13. doi:  10.1007/s10157-010-0372-2
[23] Metz CN. Fibrocytes:a unique cell population implicated in wound healing. Cell Mol Life Sci, 2003; 60, 1342-50. doi:  10.1007/s00018-003-2328-0
[24] Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2009; 179, 588-94. doi:  10.1164/rccm.200810-1534OC
[25] Choi YH, Burdick MD, Strieter RM. Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int J Biochem Cell Biol, 2010; 42, 662-71. doi:  10.1016/j.biocel.2009.12.011
[26] Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest, 2004; 114, 438-46. doi:  10.1172/JCI200420997
[27] Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med, 1994; 1, 71-81. http://www.oalib.com/references/8199691
[28] Wang JF, Jiao H, Stewart TL, et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair Regen, 2007; 15, 113-21. doi:  10.1111/wrr.2007.15.issue-1
[29] Lind M, Trindade MC, Yaszay B, et al. Effects of particulate debris on macrophage-dependent fibroblast stimulation in coculture. J Bone Joint Surg Br, 1998; 80, 924-30. doi:  10.1302/0301-620X.80B5.8710
[30] Herseth JI, Volden V, Schwarze PE, et al. IL-1beta differently involved in IL-8 and FGF-2 release in crystalline silica-treated lung cell co-cultures. Part Fibre Toxicol, 2008; 5, 16. doi:  10.1186/1743-8977-5-16